Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Gareth Jenkins, CSO at Arcinova, is newly appointed to the EPSRC


Gareth Jenkins, CSO at Arcinova, has been recently appointed to join the Strategic Advisory Network (SAN) with another 11 members.

Formed in 1994, the Engineering and Physical Sciences Research Council (EPSRC) is the main funding body for engineering and physical sciences research in the UK.

Twelve new members, including Gareth, have been recently appointed to join the SAN and as a group they will be providing the EPSRC Executive with strategic advice and recommendations. The new members will take up thier roles on the 1st October 2018. 

 

Read full article on EPSRC website




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH